GO
Loading...

Medicine

More

  • Small business view: Ebola, energy and elections Wednesday, 22 Oct 2014 | 2:25 PM ET

    And the upcoming elections are raising questions about what the new Congress is likely to do. Craig Beal has had three cancellations for safaris to places like Botswana and South Africa that are nine hours by plane from the countries with widespread Ebola outbreaks. A similar pattern emerged after riots in South Africa and a shooting last year at a Nairobi,...

  • Regulus surges on early hepatitis C drug data Wednesday, 22 Oct 2014 | 1:49 PM ET

    NEW YORK— Shares of Regulus Therapeutics more than doubled Wednesday as early testing of a hepatitis C drug appeared promising. Wedbush Securities analyst Liana said that the drug could have a major impact on hepatitis C treatment and on the future of the company. Shares of Regulus Therapeutics Inc. climbed $7.83 to $14.60 in afternoon trading.

  • As virus spreads, insurers exclude Ebola from new policies Wednesday, 22 Oct 2014 | 12:31 PM ET

    As a result, new policies and renewals will become costlier for companies opting to insure business travel to West Africa or to cover the risk of losses from quarantine shutdowns at home, industry officials told Reuters. "What underwriters are doing at the moment is they're generally providing quotes either excluding or including Ebola- and it's much more...

  • *Exploring IPO of minority stake in ViiV Healthcare. LONDON, Oct 22- GlaxoSmithKline, battered by weak U.S. drug sales and a bribery scandal in China, is looking to float its fast-growing HIV drugs business as part of a recovery plan that includes a fresh round of cost cutting. As a standalone company ViiV Healthcare would be among the top 40 companies in London's...

  • *Exploring IPO of minority stake in ViiV Healthcare. LONDON, Oct 22- GlaxoSmithKline, battered by weak U.S. drug sales and a bribery scandal in China, set out a bold recovery plan on Wednesday, including an initial public offering of part of its fast-growing HIV and AIDS drugs business. As a standalone company ViiV Healthcare would be among the top 40 companies in...

  • Oct 22- With the closest known U.S. cases of Ebola diagnosed about 160 miles away in Dallas, Cary Griffin is taking no chances. For many, the three cases of Ebola diagnosed in the United States so far since late September represent a new potential disaster and a reason to run to the store. Chad Huddleston, an anthropologist at the University of Southern Illinois at...

  • Johnson & Johnson plans Ebola vaccine testing Wednesday, 22 Oct 2014 | 7:42 AM ET

    NEW BRUNSWICK, N.J.— Johnson& Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. Johnson& Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people. Johnson& Johnson is developing the vaccine...

  • US journalist leaves hospital after Ebola recovery Wednesday, 22 Oct 2014 | 1:35 AM ET

    OMAHA, Nebraska— An American video journalist who recovered from Ebola at a Nebraska hospital left the facility Wednesday afternoon and is heading home to Rhode Island, a hospital spokesman said. Ashoka Mukpo, who contracted the virus while working in Liberia as a freelance cameraman for NBC and other media outlets, was released from the Nebraska Medical...

  • TOKYO, Oct 22- Japan's exports rose at the fastest pace in seven months in September as shipments to Asia picked up pace, but a slowdown in China, war in the Middle East and the spread of the Ebola virus mean exports may struggle to accelerate further. Now, renewed turbulence in the global markets on signs of a slowing world economy could snuff out any gains in exports,...

  • Insurer considers Ebola exclusion in some policies Tuesday, 21 Oct 2014 | 6:34 PM ET

    Global property and casualty insurer Ace Ltd. says it may exclude Ebola coverage from some of its general liability policies. The Swiss company said Tuesday that it is making the decision on a "case by case" basis for new and renewal policies under its global casualty unit, which offers coverage for U.S.-based companies and organizations that travel or have...

  • NewLink's Ebola vaccine     Tuesday, 21 Oct 2014 | 5:30 PM ET

    The World Health Organization will send thousands of doses of NewLink's experimental Ebola vaccine to West Africa in January. Dr. Charles Link, NewLink Genetics Chairman, CEO & Chief Scientific Officer, provides insight to supply capabilities, as well as the company's $1 billion deal with Roche.

  • Trading Ebola     Tuesday, 21 Oct 2014 | 3:17 PM ET

    Hardeep Walia, Motif Investing co-founder & CEO, is launching an Ebola motif which allows investors to track the companies at the forefront in fighting the virus.

  • US orders new screening for Ebola Tuesday, 21 Oct 2014 | 12:04 PM ET

    WASHINGTON— Everyone coming to the United States from the three West African countries at the center of the Ebola outbreak will now be screened for the deadly disease at one of five airports, the Homeland Security Department said Tuesday. Earlier this month, Customs and Border Protection officers at New York's Kennedy, Newark Liberty, Washington's Dulles,...

  • Hospital: American video journalist free of Ebola Tuesday, 21 Oct 2014 | 10:00 AM ET

    A recent test showed Ashoka Mukpo's blood is negative for the virus, according to the Nebraska Medical Center. Mukpo, of Providence, Rhode Island, contracted the virus while working in Liberia as a freelance cameraman for NBC and other media outlets. He has been at the Nebraska Medical Center since Oct. 6 and was the second Ebola patient to be treated there.

  • LONDON, Oct 21- An experimental Japanese flu drug that has hit the headlines because of its potential to fight Ebola may also work against norovirus, the winter vomiting bug, British researchers said on Tuesday. As with Ebola, the research is still at an early stage but a study in mice found that Fujifilm's Avigan, or favipiravir, was effective at reducing-- and in some...

  • Journalist feels fortunate to recover from Ebola Tuesday, 21 Oct 2014 | 6:52 AM ET

    OMAHA, Neb.— An American video journalist with Ebola says he feels lucky to be recovering from the deadly virus, but it's humbling to think about how many people have died from the disease in West Africa. Mukpo has been treated at the Nebraska Medical Center since Oct. 6, and doctors have said he could be released by the end of the week if tests confirm he is free of the...

  • Ebola: Why virus kills some, other people survive Tuesday, 21 Oct 2014 | 3:05 AM ET

    And while Thomas Eric Duncan died and two U.S. nurses were infected caring for him, there are successes, too: A nurse infected in Spain has recovered, as have four American aid workers infected in West Africa. The end of quarantine for 43 people in Dallas who had contact with Duncan "simply supports what most of us who know something about the disease have been saying...

  • DALLAS, Oct 20- The United States issued stringent new protocols on Monday for health workers treating Ebola victims, directing medical teams to wear protective gear that leaves no skin or hair exposed to prevent medical workers from becoming infected. The new guidelines from the U.S. Centers for Disease Control and Prevention in Atlanta come as 43 people who...

  • DALLAS, Oct 20- The United States issued stringent new protocols on Monday for health workers treating Ebola victims, directing medical teams to wear protective gear that leaves no skin or hair exposed when caring for patients infected with the virus. The new guidelines from the U.S. Centers for Disease Control and Prevention in Atlanta come as 43 people who...

  • DALLAS, Oct 20- The United States is issuing new protocols for health workers treating Ebola patients and a rapid-response military medical team will start training even as Americans' anxiety about the spread of the virus abates with 43 people declared risk free. The government's new guidelines, which were set to come out at 7 p.m. EDT on Monday, were expected to...